Recognizing that there is a rapid expansion of Biosimilars usage in clinical practice, and that the role of an oncology pharmacist is evolving and further integrating as a key member of a multidisciplinary healthcare team, ISOPP developed the Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) online education program that supports oncology pharmacists to safely and confidently introduce Biosimilars into their clinical practice and multidisciplinary healthcare team.

ISOPP presents this education program in a novel way by giving both fundamentals and advanced aspects of 1) pharmacotherapy of various cancers, 2) implementation of biosimilars in oncology practice and 3) interpretation of available scientific and regulatory data and pharmacist’s recommendations for using biosimilars in different cancers. The program consists of 10 online modules (25 hours of education).
 

See topics and learning objectives page. 

 

 

To be eligible to claim Continuing Education credits (CEUs), you must register for and complete the accredited version of the program, as well as successfully complete Modules 1 to 10 in order.  You will receive a Certificate of Completion issued by the California Society of Health-System Pharmacists (CSHP), which will state the Continuing Education credits (25) earned. You must achieve 70% or more on each Module quiz in order to proceed to the next Module. If you do not pass the Module quiz, you will need to repeat the Module until 70% or higher is achieved. You will also be asked to participate in a post-program evaluation to assess the program’s impact on the workplace. 

 

The Non-Accredited version of the program will allow you to view one or all modules in any order and you will receive a Letter of Participation from ISOPP for each module completed. No Continuing Education credits will be awarded.

 

Accreditation for this program is provided by the California Society of Health-System Pharmacists (CSHP). CSHP is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

The Program runs until March 2023 unless extended. 

 

 

We acknowledge the Faculty members, Reviewers and Task Force members for their contributions to the OPAB Program.

 

 

Individual Faculty disclosures are stated at the start of each module.

 

 

 

 This program is supported by an educational grant from Pfizer.